MEDIUM confidence: 100% data completeness, but the composite (59) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.2B— | $1.2B+5.7% | $1.2B+2.2% | $1.3B+3.2% | $1.4B+6.7% |
| EPS (dil.) | $0.90— | $1.17+30.0% | $1.01-13.7% | $1.11+9.9% | $1.25+12.6% |
| Free Cash Flow | $552M— | $566M+2.6% | $589M+4.0% | $625M+6.1% | $652M+4.4% |
| Gross Margin | 74.2% | 74.4%+0.2pp | 74.3%-0.1pp | 75.3%+1.0pp | 75.2%-0.1pp |
| Operating Margin | 36.6% | 36.5%-0.1pp | 64.9%+28.4pp | 36.6%-28.3pp | 36.7%+0.1pp |
| Net Margin | 23.4% | 29.1%+5.6pp | 24.5%-4.6pp | 26.4%+1.9pp | 28.2%+1.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 4.0%/yr (revenue basis).
Base free cash flow $622M (avg FY2023–FY2025; latest year $652M) · equity value $9.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Avg target $33 (last qtr, 7 analysts) → $33 (last mo, 5) (+0.5%).
Buy-rated share 83% → 87% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.23 | $0.28 | +23.7% |
| Jul 2026 | $0.24 | $0.24 | -2.0% |
| Apr 2026 | $0.25 | $0.41 | +65.5% |
| Feb 2026 | $0.24 | $0.44 | +84.2% |
| Oct 2025 | $0.23 | $0.31 | +36.2% |
| Jul 2025 | $0.21 | $0.28 | +31.3% |
| Apr 2025 | $0.22 | $0.23 | +3.2% |
| Feb 2025 | $0.22 | $0.27 | +22.7% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$267K over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 59 for BRX indicates a moderately attractive stock, with the short-term and long-term scores closely aligned. The stock scores high on risk, with a low beta and moderate volatility, which helps to drive up its overall score. However, its value and growth scores are more neutral, due to a P/E of 20.8 and revenue growth of 6.7%, which temper its overall attractiveness. The stock exhibits strong profitability, with an ROE of 14.1% and operating margin of 37.1%.